FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2495483957> ?p ?o ?g. }

• W2495483957 endingPage "72" @default.
• W2495483957 startingPage "61" @default.
• W2495483957 abstract "Cassia auriculata (CA) is used as an antidiabetic therapy in Ayurvedic and Siddha practice. This study aimed to understand the mode-of-action of CA via combined cheminformatics and in vivo biological analysis. In particular, the effect of 10 polyphenolic constituents of CA in modulating insulin and immunoprotective pathways were studied.In silico target prediction was first employed to predict the probability of the polyphenols interacting with key protein targets related to insulin signalling, based on a model trained on known bioactivity data and chemical similarity considerations. Next, CA was investigated in in vivo studies where induced type 2 diabetic rats were treated with CA for 28 days and the expression levels of genes regulating insulin signalling pathway, glucose transporters of hepatic (GLUT2) and muscular (GLUT4) tissue, insulin receptor substrate (IRS), phosphorylated insulin receptor (AKT), gluconeogenesis (G6PC and PCK-1), along with inflammatory mediators genes (NF-κB, IL-6, IFN-γ and TNF-α) and peroxisome proliferators-activated receptor gamma (PPAR-γ) were determined by qPCR.In silico analysis shows that several of the top 20 enriched targets predicted for the constituents of CA are involved in insulin signalling pathways e.g. PTPN1, PCK-α, AKT2, PI3K-γ. Some of the predictions were supported by scientific literature such as the prediction of PI3K for epigallocatechin gallate. Based on the in silico and in vivo findings, we hypothesized that CA may enhance glucose uptake and glucose transporter expressions via the IRS signalling pathway. This is based on AKT2 and PI3K-γ being listed in the top 20 enriched targets. In vivo analysis shows significant increase in the expression of IRS, AKT, GLUT2 and GLUT4. CA may also affect the PPAR-γ signalling pathway. This is based on the CA-treated groups showing significant activation of PPAR-γ in the liver compared to control. PPAR-γ was predicted by the in silico target prediction with high normalisation rate although it was not in the top 20 most enriched targets. CA may also be involved in the gluconeogenesis and glycogenolysis in the liver based on the downregulation of G6PC and PCK-1 genes seen in CA-treated groups. In addition, CA-treated groups also showed decreased cholesterol, triglyceride, glucose, CRP and Hb1Ac levels, and increased insulin and C-peptide levels. These findings demonstrate the insulin secretagogue and sensitizer effect of CA.Based on both an in silico and in vivo analysis, we propose here that CA mediates glucose/lipid metabolism via the PI3K signalling pathway, and influence AKT thereby causing insulin secretion and insulin sensitivity in peripheral tissues. CA enhances glucose uptake and expression of glucose transporters in particular via the upregulation of GLUT2 and GLUT4. Thus, based on its ability to modulate immunometabolic pathways, CA appears as an attractive long term therapy for T2DM even at relatively low doses." @default.
• W2495483957 created "2016-08-23" @default.
• W2495483957 creator A5001996295 @default.
• W2495483957 creator A5003357792 @default.
• W2495483957 creator A5012504588 @default.
• W2495483957 creator A5026643759 @default.
• W2495483957 creator A5065035817 @default.
• W2495483957 creator A5069477629 @default.
• W2495483957 creator A5081285661 @default.
• W2495483957 date "2017-02-01" @default.
• W2495483957 modified "2023-10-05" @default.
• W2495483957 title "Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes" @default.
• W2495483957 cites W1519266993 @default.
• W2495483957 cites W1536052747 @default.
• W2495483957 cites W1546226477 @default.
• W2495483957 cites W1967682927 @default.
• W2495483957 cites W1969364921 @default.
• W2495483957 cites W1970391485 @default.
• W2495483957 cites W1971316445 @default.
• W2495483957 cites W1971524424 @default.
• W2495483957 cites W1976536739 @default.
• W2495483957 cites W1985393882 @default.
• W2495483957 cites W1988037271 @default.
• W2495483957 cites W1989463122 @default.
• W2495483957 cites W1990587975 @default.
• W2495483957 cites W1990902267 @default.
• W2495483957 cites W1992725304 @default.
• W2495483957 cites W1996854381 @default.
• W2495483957 cites W1998493448 @default.
• W2495483957 cites W1998767819 @default.
• W2495483957 cites W1999278785 @default.
• W2495483957 cites W2000541041 @default.
• W2495483957 cites W2006717141 @default.
• W2495483957 cites W2008406456 @default.
• W2495483957 cites W2013966444 @default.
• W2495483957 cites W2015670148 @default.
• W2495483957 cites W2019044526 @default.
• W2495483957 cites W2020958149 @default.
• W2495483957 cites W2032132422 @default.
• W2495483957 cites W2032729761 @default.
• W2495483957 cites W2040049214 @default.
• W2495483957 cites W2040700449 @default.
• W2495483957 cites W2044270116 @default.
• W2495483957 cites W2051713357 @default.
• W2495483957 cites W2062756785 @default.
• W2495483957 cites W2069909920 @default.
• W2495483957 cites W2078760905 @default.
• W2495483957 cites W2085553315 @default.
• W2495483957 cites W2090658545 @default.
• W2495483957 cites W2096541451 @default.
• W2495483957 cites W2100408829 @default.
• W2495483957 cites W2121612327 @default.
• W2495483957 cites W2125231550 @default.
• W2495483957 cites W2132926880 @default.
• W2495483957 cites W2145323594 @default.
• W2495483957 cites W2146766276 @default.
• W2495483957 cites W2147130152 @default.
• W2495483957 cites W2148496196 @default.
• W2495483957 cites W2154319440 @default.
• W2495483957 cites W2159216974 @default.
• W2495483957 cites W2162194965 @default.
• W2495483957 cites W2167706579 @default.
• W2495483957 cites W2168427689 @default.
• W2495483957 cites W2168990503 @default.
• W2495483957 cites W2170146596 @default.
• W2495483957 cites W2180405752 @default.
• W2495483957 cites W2338330067 @default.
• W2495483957 cites W4212865600 @default.
• W2495483957 cites W4248065637 @default.
• W2495483957 doi "https://doi.org/10.1016/j.jep.2016.07.058" @default.
• W2495483957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27452659" @default.
• W2495483957 hasPublicationYear "2017" @default.
• W2495483957 type Work @default.
• W2495483957 sameAs 2495483957 @default.
• W2495483957 citedByCount "20" @default.
• W2495483957 countsByYear W24954839572017 @default.
• W2495483957 countsByYear W24954839572018 @default.
• W2495483957 countsByYear W24954839572019 @default.
• W2495483957 countsByYear W24954839572020 @default.
• W2495483957 countsByYear W24954839572021 @default.
• W2495483957 countsByYear W24954839572022 @default.
• W2495483957 countsByYear W24954839572023 @default.
• W2495483957 crossrefType "journal-article" @default.
• W2495483957 hasAuthorship W2495483957A5001996295 @default.
• W2495483957 hasAuthorship W2495483957A5003357792 @default.
• W2495483957 hasAuthorship W2495483957A5012504588 @default.
• W2495483957 hasAuthorship W2495483957A5026643759 @default.
• W2495483957 hasAuthorship W2495483957A5065035817 @default.
• W2495483957 hasAuthorship W2495483957A5069477629 @default.
• W2495483957 hasAuthorship W2495483957A5081285661 @default.
• W2495483957 hasBestOaLocation W24954839572 @default.
• W2495483957 hasConcept C104317684 @default.
• W2495483957 hasConcept C112446052 @default.
• W2495483957 hasConcept C134018914 @default.
• W2495483957 hasConcept C142724271 @default.
• W2495483957 hasConcept C150903083 @default.
• W2495483957 hasConcept C161573976 @default.
• W2495483957 hasConcept C185592680 @default.

• next